John Schembri

Vice President, Finance

John Schembri is Vice President, Finance of Akero Therapeutics. John has been an accounting and finance officer to many successful biotechnology companies since 1998. Prior to joining Akero, John was the Vice President of Finance at Global Blood Therapeutics, where he facilitated the company’s IPO, the Chief Financial Officer of BiPar Sciences, where he helped sell the company to Sanofi-Aventis, and the Vice President & Controller of Sirna Therapeutics, where he aided the sale of the company to Merck. He holds a BBA from Cal Poly San Luis Obispo and is a Certified Equity Professional and a licensed CPA in California (inactive).